^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    OICR-9429

    i
    Other names: OICR-9429
    Company:
    FACIT, Ontario Institute for Cancer Research, Structural Genomics Consortium
    Drug class:
    WDR5 inhibitor